Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP AF First: Cryoballoon Ablation vs Drugs for Paroxysmal AF
NCT03118518Completed
- Sponsor
- Medtronic
- Start
- Jun 2017
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Medtronic. Primary endpoints: Percentage of Participants With Treatment Success at 12 months and Rate of Composite List of Serious Adverse Events at 12 months. Started Jun 2017; status: completed.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03118518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03118518.